Wis. maker of ablation devices nears financing target of $19M

08/1/2013 | MassDevice.com (Boston)

An equity financing round targeted at $19 million has pulled in $14 million for NeuWave Medical, a spinoff of the University of Wisconsin-Madison. The company is the maker of the Certus 140 soft-tissue ablation system, which is used primarily to aid in the treatment of kidney, liver and lung tumors.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC